III Steering Committee Meeting. Mexico, DF. May 2003. Annex 4. Bioequivalence Working Group. J. Molzon
![]() |
III Steering Committee Meeting. Mexico, DF. May 2003. Annex 4. Bioequivalence Working Group. J. Molzon 31 p. Justina A. Molzon, M.S. Pharm., J.D. Associate Director for International Affairs Center for Drug Evaluation and Research/USFDA |